The University of Kentucky Center for Molecular Medicine through a NIH/NIGMS funded Center of Biomedical Research Excellence (COBRE) grant anticipates funding pilot grants in the amount of $50,000 per year for up to two years. Research projects should fit into the general theme of the molecular basis of human disease. Three categories of grants will be considered:
The National Conferences on Undergraduate Research (NCUR) 2014 will be held on The University of Kentucky campus on April 3-5, 2014 – just a week away! Over 4000 students and mentors will be in participation. NCUR is an annual celebration of undergraduate research, scholarship, and creative activity in all fields of study for students across the country and beyond. For full details, see http://www.cur.org/ncur_2014/.
We all know that exercise is good for us — it can help us lower blood pressure and cholesterol, maintain a healthy weight, and even improve mood and sleep. But can exercise improve the brain, especially as we age?
A multidisciplinary group of University of Kentucky researchers is working to answer that question.
The Department of Health and Human Services (DHHS) Office of Inspector General has released a plan to review that grantee institutions are complying with Conflict of Interest regulations. To see the report, click here. It is noted within the report starting on page 30. The Univeristy of Kentucky regulations on Conflict of Interest are available here.
Translational research — the process of moving a laboratory discovery into clinical applications — is a long and complex process requiring diverse expertise, ranging from basic science and regulatory affairs to participant recruitment and rclinical application. According to the National Institutes of Health (NIH), it can take more than a decade for a lab discovery to result in a new treatment, medical device, or prevention method.
Nagaraj Kerur, a post-doctoral fellow in the lab of Dr. Jayakrishna Ambati, Department of Ophthalmology and Visual Sciences at the ºÃÉ«ÏÈÉú, has received a prestigious K99/R00 award from the National Eye Institute (NEI). This Pathway to Independence award is one of only four given by the NEI in the nation annually.
The award will provide up to five years of support consisting of two phases. The initial mentored phase will provide support for up to two years for the most promising and exceptionally talented new investigators.
When Premi Haynes was growing up in Pune, India, she attended Stella Maris High School, an English language convent school founded by Swiss nuns. Her second grade singing class used a book of English songs. One of the songs was "My Old Kentucky Home." At that time, Haynes had never heard of Kentucky, had no idea where it was, and had no particular ambition to go there.
Some 20 years and a twist of fate later, today Haynes is defending her Ph.D.
Questions continue to come up related to compliance with the NIH Public Access Policy. We are pleased to provide this additional resource as investigators work through the steps to comply with this policy. This PowerPoint is from a presentation at the June 2013 NIH Regional Conference. To view the presentation, click on the file below.
In addition to providing high quality health care, the University of Kentucky is also committed to finding new treatments, tests, and cures for diseases. Now, patients at ºÃÉ«ÏÈÉú can contribute to that effort by agreeing to participate in the Research Registry and Specimen Bank, or the "biobank."
When you have a medical procedure that involves, for example, drawing blood or sampling tissue, there is often material left over from the testing process that would otherwise be thrown away.
Nearly 700 researchers, students, policymakers and community members will gather at the Lexington Convention Center March 27 to share research, mentor junior faculty, and enhance collaborations in clinical and translational science, with special focus on addressing health disparities in Appalachia.
All active investigators will receive a reminder to update their Financial Disclosure Forms during the month of March. EAG is sending the email in batches. The first was sent on February 18 and they are currently through the S’s.
As a reminder, clinical trial F&A rates for industry-funded studies increased effective 7/1/2013. Please be sure to use this rate in study budgets being discussed with sponsors. Information can be found here: http://www.research.uky.edu/ospa/info/clinical_info.html.
In our continuing effort to keep the College of Medicine informed about the 2014 National Conference on Undergraduate Research http://www.cur.org/ncur_2014/, which will take place here at ºÃÉ«ÏÈÉú on April 3 – 5, please note the following ways to encourage student participation:
NIH PIs are reminded that compliance with the NIH Public Access Policy is applicable to all awards with start dates July 1, 2013, or later. More information can be found at this link, http://publicaccess.nih.gov/. Also available is a PowerPoint presentation as prepared by Dr. Tom Kelly, Associate Dean for Research, College of Nursing, and Professor, Dept. of Behavioral Science.
Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.
The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2014 funds.
Sent on behalf of Brandy Nelson, University of Kentucky Biosafety Officer and Responsible Official:
Per the Code of Federal Regulations (7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73) possession, use or transfer of the infectious agents and toxins listed below requires registration with the Centers for Disease Control and Prevention and/or United States Department of Agriculture. Non-compliance with these regulations may result in criminal penalties, including fines and incarceration, affecting the University of Kentucky and/or the individual in possession of the material.
ºÃÉ«ÏÈÉú student Melanie Pleiss has received the PhRMA Foundation Pre-Doctoral Fellowship in Pharmacology/Toxicology.
The fellowship is a two year award that provides recipients with an annual stipend of $20,000 to support the research activities of a doctoral program.
"The application process is extremely competitive, with just one applicant per institution allowed to apply and only a certain number of awards given to U.S. schools of medicine, pharmacy, dentistry or veterinary medicine," said Dr.
